Authors: Butkiewicz, N Yao, NH Wong, WD Wright-Minogue, J Ingravallo, P Zhang, RM Durkin, J Standring, DN Baroudy, BM Sangar, DV Lemon, SM Lau, JYN Hong, Z

Citation: N. Butkiewicz et al., Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3, J VIROLOGY, 74(9), 2000, pp. 4291-4301

Authors: Hong, Z Standring, DN Baroudy, B Lau, JYN

Citation: Z. Hong et al., Development of novel anti-HCV therapies: HCV protease, helicase, and polymerase as therapeutic targets, ACT GASTR B, 63(2), 2000, pp. 210-212

Authors: Genovesi, EV Lamb, L Medina, I Taylor, D Seifer, M Innaimo, S Colonno, RJ Standring, DN Clark, JM

Citation: Ev. Genovesi et al., Efficacy of the carbocyclic 2 '-deoxyguanosine nucleoside EMS-200475 in the woodchuck model of hepatitis B virus infection (vol 42, pg 3209, 1998), ANTIM AG CH, 43(3), 1999, pp. 726-726

Authors: Seifer, M Hamatake, RK Colonno, RJ Standring, DN

Citation: M. Seifer et al., In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir, ANTIM AG CH, 42(12), 1998, pp. 3200-3208

Authors: Genovesi, EV Lamb, L Medina, I Taylor, D Seifer, M Innaimo, S Colonno, RJ Standring, DN Clark, JM

Citation: Ev. Genovesi et al., Efficacy of the carbocyclic 2 '-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection, ANTIM AG CH, 42(12), 1998, pp. 3209-3217